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Objectives: The objective of this study was to prospectively compare diag-
nostic performance and time efficiency of a double-reading paradigm in which
a first-reader computer-aided detection (CAD) is followed by a fast 2-
dimensional review (DR FR-CAD) with those of a double reading with
second-reader CAD (SR CAD).
Materials and Methods: The local ethical committee approved this study.
Consecutive immunological patients who have positive results for fecal im-
munological test who were scheduled for colonoscopy were enrolled for a 10-
month period. Computed tomographic colonography studies were read with
CAD (CAD COLON-1.20; im3D, Turin, Italy) by using both SR CAD (ap-
plied after unassisted interpretation primary 2-dimensional) and DR FR-CAD
(CAD-prompts evaluation followed by a fast 2-dimensional review) in ran-
domized order with the radiologist for each reading paradigm masked to the
other reader’s results.
Per-patient sensitivity and specificity of unassisted and CAD-assisted
readings for detecting 6-mm adenomas or larger were calculated by using
unblinding colonoscopy as reference standard. Reporting times were also
calculated. Pairwise comparisons were performed.
Results: A total of 182 participants (median age, 65 years; range, 58Y76) were
included in the final analysis. Of these, 93 (51%) had at least 1 cancer or a
6-mm adenoma or larger. At the 6-mm threshold, sensitivity of unassisted
reading (79.6%; 95% confidence interval [CI], 69.9Y87.2) increased signifi-
cantly with the use of both SR CAD (86.0%; 95% CI, 77.3%Y92.3%) and DR
FR-CAD (89.2%; 95% CI, 81.1%Y94.7%), without differences between CAD
readings (P = 0.500). No significant differences in specificity among the
3 paradigms were observed. Double reading with first-reader CAD required
less reading time than that for SR CAD (378 vs 496; $118 seconds; P G 0.001)
and was 59 seconds longer than the unassisted reading (P = 0.058).
Conclusions: When compared with unassisted reading, a double-reading
paradigm in which first-reader CAD is followed by a fast 2-dimensional re-
view improves the adenoma detection rate to the same level achieved by a
second-reader CAD while decreasing reporting times.
Key Words: CT colonography, computer-aided detection, screening,
colon-rectal cancer, adenomas
(Invest Radiol 2014;49: 173Y182)
Computed tomographic colonography (CTC) has been consideredamong the available strategies for colorectal cancer (CRC)
screening.1 However, several issues still need to be addressed before
the adoption of CTC as the primary test for mass screening programs.
The interpretation of CTC screening is challenging. The necessity of
viewing a large number of images to detect a small number of clin-
ically significant lesions, the subtle nature of many radiological
characteristics of colonic lesions, and radiologist fatigue or distrac-
tion may contribute to false-negative CTC interpretations.2Y5 Double
reading of medical images has been shown to improve sensitivity in
some settings, such as in the interpretation of mammograms.6 How-
ever, CTC interpretation is time-consuming7Y9; therefore, the in-
volvement of an additional expert for double reading would not be
cost-effective.10 This is especially true when considering that CTC
cost already needs to be reduced to become a cost-effective alterna-
tive to other screening tests.11 Computer-aided detection (CAD) has
the potential to improve the cost-effectiveness of CTC for population
screening by increasing detection and/or reducing reporting times.12
As a second-reader CAD (SR CAD), applied after a complete and
unaided assessment, CAD has been shown to increase reader’s sen-
sitivity, albeit at the cost of increasing reading times.13Y18 This is
generally undesirable if a large number of cases must be read se-
quentially as in a screening setting. A potentially more time-efficient
paradigm is the first-reader CAD, in which reader’s interpretation is
restricted to CAD-prompts alone.19 However, with this mode, colonic
areas unprompted by CAD will be inevitably ignored and the benefit
of first-reader CAD remains controversial. Furthermore, detection of
colonic findings typically not targeted by CAD systems, such as
masses or atypical lesions, poses challenges.20Y22
A potential approach to overcome these limitations is to add,
after CAD-prompts evaluation, a short 2-dimensional review of the
unprompted areas of the colon.23,24 A prior study on an artificially
and retrospectively selected population24 suggests that this CAD
approach maintains sensitivity and specificity of unassisted reading
while reducing reporting times. However, the retrospective nature of
this evaluation imposes important limitations. Prospective studies are,
therefore, needed to assess its diagnostic performance in a working
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clinical setting. Furthermore, the issue whether this CAD reading
paradigm could have advantages over the widely tested SR CAD
remained unanswered. Thus, a prospective investigation on the use of
different formats for CTC-CADYassisted interpretation was warranted.
This study was designed to prospectively compare diagnostic perfor-
mance and time efficiency of a double-reading paradigm in which a
first-reader CAD is followed by a fast 2-dimensional review (DR FR-
CAD) with those of a double reading with SR CAD.
MATERIALS AND METHODS
The company im3D (Torino, Italy) supported the study by
partially financing it and by providing the CAD interpretation hard-
ware and viewing software. Two authors (L.C. and A.B.) are employees
of im3D, and 1 author (G.I.) is a research consultant for im3D. All au-
thors (including those who are employees of or consultants for the
sponsoring company) gave substantial contribution to the design of the
study, clinical investigation, data collection, data analysis, and/or man-
uscript drafting. Those authors who are not employees of or consultants
for the sponsoring industry had access to and control of the data that
might have represented a conflict of interest for those authors who are
employees or consultants for the sponsoring company.
Design and Patient Population
This was a single-center cross-sectional study, in which each
participant underwent CTC and colonoscopy on the same day. Local
institutional board approval was obtained, and all participants pro-
vided written informed consent before enrollment. Patients aged
59 to 69 years with a clinical indication for colonoscopy due to a
positive fecal immunological test (FIT) result from a population-
based screening program25 were eligible. Participants were excluded
if they had a clinical diagnosis of familial adenomatous polyposis or
hereditary nonpolyposis CRC syndrome and inflammatory bowel
disease or if they had psychological or physical conditions that
contraindicated colonoscopy. Enrollment started in October 2009 and
finished in August 2010.
Computed Tomographic Colonography Protocol
All patients followed a low-residue diet starting 3 days before
the examination and a liquid diet on the day of the examination.
Bowel preparation consisted of administration of 1 sachet of
Macrogol 3350-based mild laxative (Movicol; Norgine Italia, Milan,
Italy) at each of the 3 main meals, starting 3 days before examination
in patients who had no constipation. A 45-mL solution of phospho-
soda vials (Fosfo-Soda Fleet; Bergamon, Rome, Italy) at 8 AM and
6 PM of the day before examination was used in patients with con-
stipation (ie, frequency of defecation less than 3 times per week and
stool consistency e3 on the Bristol stool form scale). On the day of
examination, all patients ingested a 70-mL dose of sodium diatrizoate
and meglumine diatrizoate solution (Gastrografin; Bayer Schering
Pharma, Milan, Italy) diluted in 500 mL of water 2 hours before
CTC. The patients were also asked to drink an additional 500 mL of
water. The patients were placed on a computed tomographic (CT)
table, and a small flexible rectal catheter was positioned. Immediately
before scanning, pneumocolon was achieved by means of the infla-
tion of carbon dioxide using automatic device (Protocol Colon
Insufflator; Bracco, Milan, Italy). n-Butylscopolamine was not ad-
ministered. Computed tomographic colonography was performed
with the participant in the supine and prone positions with the fol-
lowing scanning protocol: 120 kilovolt (peak) (kV[p]) (140 kV[p]
in patients with obesity [body mass index, 930 kg/m2]); 50 mA s (ef-
fective) or less (without the use of any system for dose modulation);
a rotation time of 0.5 to 0.7 seconds; a section thickness not greater than
1.25 mm; and a reconstruction interval of 1.25 mm. The total effective
dose of the study was less than 4 mSv. The median total dose-length
product for all patients was 246 mGyIcm (mean [SD], 252 [60];
interquartile range, 234Y257).
Intravenous contrast medium was not used.
Computer-Aided Detection System
A commercially available visualization platform was used
with an integrated CAD system (CAD COLON-1.20; im3D, Torino,
Italy). The CAD algorithm and its performance have been described
in detail elsewhere.13,26Y28 In brief, after electronic cleansing, the
software extracts the colon from input CT images by applying a
3-dimensional regionYgrowing algorithm. Colon surface voxels with
suspicious curvature properties are then selected, and those whose
shape and curvature indexes are within a predefined range are clus-
tered according to spatial density rules to yield initial marks and
candidates are extracted. A classifier using shape, density, and tex-
ture information then attributes a score to each candidate. Candidate
lesions with a score higher than a certain threshold (operating point)
are then shown to the user. The corresponding CAD prompts are
displayed on both 2- and 3-dimensional images with rectangular
bounding boxes. The CAD operative point was set by the manufac-
turer to reach a sensitivity of 90% (95% confidence interval [CI],
86%Y93%) for lesions of 6 mm or larger, with a corresponding false-
positive rate of 10 false-positives per series, as computed in a retro-
spective evaluation of a previously published series.28 The selected
operative point of our CAD remained constant throughout the study.
Image Interpretation
Three experienced radiologists (range, 600Y1200 examina-
tions; 5Y10 years of experience, at least 200 CTC examinations
verified by colonoscopy) participated in the study. All readers have
been using the CAD system used for this study for at least 2 years.
Immediately before colonoscopy, the CTC study was ran-
domly assigned to be prospectively read by using either SR CAD or
DR FR-CAD paradigm by 1 of the 3 study readers. This first reading
was used for segmental unblinding colonoscopy (see below). One to
2 weeks later, the study was reviewed by a second radiologist, blinded
to the first CTC reading and colonoscopy results, with the opposing
CAD paradigm. This reading represented the second CTC reading.
Thus, each case was independently double read by 2 of the 3 study
radiologists by using the 2 different CAD reading implementations
(SR CAD and DR FR-CAD). For both readings, the radiologists were
aware of disease prevalence and were told to ignore polyps 5 mm or
less. Also, the readers were free to use the full functionality of the
workstation (ie, 2-dimensional transverse images, multiplanar re-
construction, 3-dimensional view, and full endoluminal fly-through),
as normally done in clinical practice.
Second-Reader CAD
We used a sequential reading design to minimize the number
of reading sessions required in our study. In the first phase, the ra-
diologists interpreted the study without activating the CAD algo-
rithm. A 2-dimensional primary reading mode with the use of
3-dimensional viewing for problem solving was used in this phase.
This interpretation served as benchmark for unassisted CTC perfor-
mance. The radiologists documented polyp morphology as well as its
maximal transverse diameter and assigned each finding to the colonic
segment. The position on CT images of each detected lesion was
marked by drawing a 3-dimensional region of interest with freehand
tool imbedded in the software. The radiologists also provided the
overall confidence that the case was abnormal (scored from 0 [least
confident] to 100 [most confident]), and they assessed the images
according to C-RADS guidelines.29 Interpretation time (defined as
the time taken to read the data once loaded on the workstation) was
automatically recorded. Once the unassisted reading was complete,
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the results were locked by the software (ie, it was impossible for the
readers to change the results of unassisted interpretation). At this
stage, the radiologist activated the CAD system, which pinpointed a
series of lesion candidates on both prone and supine acquisitions.
The radiologists then examined all lesion candidates by using both
2-and 3-dimensional viewing. Each lesion candidate was system-
atically rejected as a CAD false-positive finding or accepted as an
additional lesion. Any additional lesion was documented by the
readers exactly as done in the previous phase. The time taken for
additional CAD-assisted review, the overall reader confidence, and
the C-RADS score were recorded, as described before. For each
lesion reported at this phase, the 3-dimesional box on CT images
automatically estimated by the CAD was also stored.
Double Reading With First-Reader CAD
A sequential reading mode was used. In the first phase, the
radiologist activated the CAD system and then examined all lesion
candidates, on both prone and supine series, by using both 2- and
3-dimensional viewing. Each lesion candidate was systematically
rejected as a CAD false-positive finding or accepted as a suspicious
abnormality. This phase of reporting was defined as FR-CAD. Doc-
umentation of perceived abnormalities, the overall diagnostic confi-
dence, C-RADS score, and the reading time were noted as described
previously. Also, positions of all accepted CAD findings were
recorded by saving the 3-dimensional boxes on CT images auto-
matically estimated by the CAD. After evaluating the CAD de-
tections, an additional quick 2-dimensional evaluation of the data set
was performed in both supine and prone positions to address areas
unprompted by CAD. Any additional detection was documented
exactly as before and was manually marked by the reader by tracing
a 3-dimensional box on CT images containing the lesion. The overall
diagnostic confidence, C-RADS score, and the reading time used in
this phase were automatically recorded for each patient.
Colonoscopy Protocol
Bowel Preparation
Colon hydrotherapy (HCT)30,31 was used as bowel prepara-
tion for the subsequent colonoscopy. The procedure was performed
by appropriately trained nurses at least 1 hour after CTC examina-
tion. In the left lateral position, a rectal speculum was positioned and
connected to the HCT apparatus (Hydroterapy CD mod. 004 RA;
Bionex S.R.L., Milan, Italy). The patient was then rotated in the
supine position, and purified, ultraviolet light-irradiated water, pre-
heated to a temperature comprised between 36-C and 39-C, was
infused through the rectal tube at low pressure (filling phase). The
flow was stopped at the onset of an urgency to evacuate, and the
outflow valve was opened, allowing spontaneous emptying of bowel
contents (emptying phase). During the emptying phase, the operator
performed a gentle circular massage of the abdominal wall to help
loosening the stool residues from the colon wall and to encourage
peristalsis. A series of filling and emptying phases were carried out
until the discharging effluent was clear of fecal matter. The speculum
was then removed. Time taken to complete the HCT sessions varied
between 25 and 85 minutes with a mean of 55 minutes (range,
15Y85 minutes).
Colonoscopy Procedure
Colonoscopy was performed at least 3 hours after CTC. Pa-
tient sedation was not used according to the common clinical practice
of our institute. The endoscope was advanced to the cecum, and the
entire length of the bowel was examined during endoscope with-
drawal. The endoscopist was initially blinded to the result of CTC;
at the end of each bowel segment evaluation, CTC results for that
segment were disclosed (segmental unblinding). If a lesion measur-
ing 6 mm or larger was seen at CTC but missed at colonoscopy, the
segment was carefully re-examined to resolve discrepancy, as pre-
viously reported.32 All detected lesions were photographed and
measured by using the open biopsy forceps. Visible lesions were
endoscopically removed; those retrieved were sent for local pa-
thologist evaluation and classified according to the World Health
Organization criteria.33 Complications occurring during or imme-
diately after colonoscopy (eg, bleeding, perforation) were system-
atically recorded.
Matching of CTC Detections With CC Polyps
A lesion found at the first CTC reading (by using either SR
CAD or DR FR-CAD) was matched to a corresponding one found at
colonoscopy when it was in the same or an adjacent colonic segment
and its size differed by no more than 50%.9 Matching was performed
during the colonoscopy procedure. To match a lesion found at the
second CTC reading (by using either SR CAD or DR FR-CAD) to a
corresponding one found at colonoscopy, a lesion matching process
was electronically performed as follows. A CTC finding was matched
to a colonoscopy polyp if (1) there were location matches between
CTC and colonoscopy within 1 colonic segment and size matches
within a 50% error margin or (2) if there was an overlap between the
bounding box of this lesion and that of a lesion reported at the first
CTC reading with a matching polyp on colonoscopy. This criterion
was overruled by the first criterion for polyps found at colonoscopy
that were not found at the first CTC interpretation. An experienced
radiologist (G.I.) adjudicated discrepancies in the results of the lesion-
matching analysis.
The Reference Standard
The reference standard was unblinded colonoscopy, along
with a histologic evaluation of the removed lesions. Advanced ade-
nomas were defined as lesions showing high-grade dysplasia, more
than 20% villous component, or a size of 10 mm or larger. Advanced
neoplasia was defined as cancer or advanced adenoma. We grouped
serrated sessile adenomas and other adenomas together unless they
had specific features of advanced adenomas. The primary study
metric was performance for adenoma detection. Therefore, a negative
result at reference standard was assigned to all patients with no 6-mm
adenomas or larger at endoscopy; otherwise, the patients were
assigned a positive result. When 2 or more adenomas were removed
in the same patient, the one with the worst histology was classified as
the index lesion; for multiple lesions with the same histology, the
largest one was considered.
Statistical Analysis
Statistical analyses were performed by using software R (The
R Foundation for Statistical Computing).34 All statistical tests were
2-sided and were considered statistically significant at P G 0.05. All
CIs were reported at the 95% level.
Primary End Points
The primary end point of the study was the per-patient sensi-
tivity and specificity of CTC with unassisted reading, SR CAD, and
DR FR-CAD for detecting patients with at least one 6-mm adenoma
or larger. We defined, as a positive CTC result with each reading
paradigm, the identification of at least one 6-mm lesion or larger.
This determination was then deemed as either a true positive or false
positive depending on whether the reference standard confirmed the
presence of a 6-mm adenoma or larger. Negative results of CTC
with each reading paradigm were similarly deemed as true negatives
or false negatives depending on the results of the reference stan-
dard. Sensitivity, specificity, positive predictive value, and negative
Investigative Radiology & Volume 49, Number 3, March 2014 Computer-Aided Detection for CTC Screening
* 2014 Lippincott Williams & Wilkins www.investigativeradiology.com 175
Copyright © 2014 Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.
predictive value, along with 95% CIs, were calculated for each
reading modality according to lesion size range. The McNemar test
for correlated proportions was used to assess significance for differ-
ences in sensitivity and specificity. Accuracy of all reading modali-
ties was also assessed with the use of receiver operating characteristic
(ROC) curves. The ROC curves were estimated from the continuous
confidence scale with the use of data pooled among the radiologists
because of the small number of positive cases read by each radiolo-
gist. Smooth ROC curves were generated under binomial assump-
tions by using software implemented for the R statistical system.35
Interpretation times were compared by using paired t test. The re-
lationships between the reporting time and the number of CAD
prompts per series and the reporting time and reading methods were
analyzed by mixed-effects regression model36,37 to account for the
data correlation (ie, the same cases read with all reading modalities).
Secondary End Points
Additional secondary analyses focused on the evaluation of
per-polyp performance. Per-polyp sensitivity of CTC with each
reading modality was calculated as the percentage of matching
findings among all lesions sized in the range of interest that were
found at colonoscopy, using the matching algorithm described pre-
viously. Per-polyp analysis was not limited to adenomas.
Multivariate logistic regression analysis was undertaken to
identify factors associated with the risk for missing polyps at CAD-
assisted reading. We fitted a model in which polyps were considered
as random, but CAD reading modality and polyp features were con-
sidered as fixed.36,37 Tests of interaction assess whether there is any
important effect modification, for example, whether the effect of
1 factor (such as reader paradigm) changes for different levels of other
factors (such as polyp histology or morphology). To assess the validity
of the mixed-effects analyses, we performed likelihood ratio tests
comparing the models with fixed effects to the null models with only
the random effects. We rejected results in which the model including
fixed effects did not differ significantly from the null model. Data were
presented as odds ratios (ORs) and 95% CIs.
Sample Size Estimate The sensitivity of SR CAD in detecting pa-
tients with 6-mm adenomas or larger was estimated to be approxi-
mately 85% with a specificity of 90%.13 A power calculation (at 5%
significance and 80% power) performed on the basis of these esti-
mates suggested that at least 84 patients containing at least one 6-mm
adenoma or larger were required to detect a 10% difference in ade-
noma detection between SR CAD and DR FR-CAD (85% vs 75%).
Because the expected prevalence of target cases was originally esti-
mated to be approximately 45%, it was calculated that at least
190 participants would have to be enrolled for the study.
RESULTS
Two hundred participants were enrolled in the study. Of these,
18 patients were excluded from the analysis because of the following
FIGURE 1. Flow diagram of the study.
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reasons: 1 patient for CTC refusal, 4 for protocol violation (CTC
studies read by 2 radiologists with the same CAD paradigm), 7 for
nondiagnostic image quality (2 studies were judged as nondiagnostic
examinations with SR CAD; 3, with DR FR-CAD; and 2, with both
CAD readings), and 6 for missing data on reference standard (3,
colonoscopy refusal; 3, histological data unavailable). Thus, the fi-
nal population was 182 (91.4%) participants (Fig. 1). Patient de-
mographics and clinical characteristics are listed in Table 1. The
median age was 65 years (range, 58Y76 years), and there was no age
difference between men (median, 65 years; range, 59Y77 years) and
women (median, 65 years; range, 58Y76 years) (P = 0.900). At co-
lonoscopy, cecal intubation was achieved in 178 cases, accounting
for a completion rate of 98%. No lesion of 6 mm or larger was
detected at CTC in the segments not reached in the incomplete co-
lonoscopies. At reference standard, 93 (51%) patients were repor-
ted as having positive findings (ie, containing at least one cancer or
6-mm adenoma or greater). Thirteen (7%) and 63 (34%) patients
were found to have a cancer and an advanced adenoma as the most
severe lesion, respectively. Using a CTC cutoff size of 6 mm, unas-
sisted, SR CAD, and DR FR-CAD reading yielded positive results in
80 (44%), 89 (49%), and 91 (50%) patients, respectively.
Per-Patient Analysis
Table 2 shows per-patient performance of each reading mo-
dality. At 6-mm threshold, CTC sensitivity in detecting adenomas
with unassisted reading was 79.6% (95% CIs, 69.9Y87.2). Sensitivity
increased significantly with the use of SR CAD (86.0%; 95%
CIs,77.3Y92.3; P = 0.020) and DR FR-CAD (89.2%; 95% CIs,
81.1%Y94.7%, P = 0.030), with no significant differences between
CAD paradigms (P = 0.500). Also, sensitivity of FR CAD alone
(84.5%; 95% CIs, 76.0%Y91.5%) was not significantly lower than
that of either SR CAD (P = 1.000) or DR FR-CAD reading (P =
0.130). At 10-mm threshold, sensitivity of unassisted reading
(93.3%) for detecting adenomas larger than 9 mm at colonoscopy
was not significantly inferior to that of SR CAD (97.6%, P = 0.400)
and that of DR FR-CAD (98.6%, P = 0.500). All patients with can-
cers were detected with all 3 reading strategies for a sensitivity of
100%. Of the 80 patients with positive findings detected with SR
CAD, 6 patients (4 advanced adenomas, 2 adenomas) initially missed
on the unassisted reading were identified during the CAD component
of the second-reader paradigm. Of the 83 patients with positive
findings detected with DR FR-CAD, 4 patients (one 33-mm cancer,
2 advanced adenomas, 1 adenoma) originally missed by CAD were
identified during the 2-dimensional review component of DR FR-
CAD. During the unassisted reading, there were 6 patients who are
false positive for a specificity of 93.3% (83/89); the application of SR
CAD resulted in a total of 3 additional false-positive cases, for a
specificity of 89.9% (80/89; P = 0.300). At the FR-CAD reading,
6 patients with negative findings were incorrectly classified as in-
dividuals with 6-mm lesions or larger, for a specificity of 93.3%
(83/89); application of the 2-dimensional review resulted in a total of
2 additional false-positive cases for a specificity of 91.0% (81/89;
P = 0.480). Diagnostic performances of CTC reading paradigm as-
suming a 10 mm polyp size threshold for colonscopy referral are shown
in Supplemental Digital Content 1 (http://links.lww.com/RLI/A140).
The number of CAD prompts per series did not adversely in-
fluence the readers’ specificity for both CAD paradigms; at the multi-
variate analysis, the ORs of having a false positive per 1-unit increase in
the number of CAD prompts were 1.1 (95% CI, 0.96Y1.2; P = 0.200)
for SR CAD and 0.99 (95% CI, 0.88Y1.1; P = 0.800) for DR FR-CAD.
The reader individual performances are listed in Supplemental Digital
Content 2 (http://links.lww.com/RLI/A113). The individual sensitivity
ranged from 74% to 85% (P = 0.700) for the unassisted reading, from
84% to 89% (P = 0.800) for SR CAD, and from 80% to 96%
(P = 0.400) for DR FR-CAD. The individual specificity ranged be-
tween 91% and 95% (P = 0.401) for the unassisted reading, be-
tween 88% and 91% (P = 0.917) for SR CAD, and between 80% and
95% (P = 0.200) for DR FR-CAD.
Receiver Operating Characteristic Analysis
The mean area under curve (AUC) was 86.5% (95% CIs,
81.3%Y91.8%) for the unassisted reading; 90.1% (95%CIs, 85.4%Y94.7%)
for SR CAD, and 92.0% (95% CIs, 87.9%Y96.1%) for DR FR-CAD.
The use of CAD resulted in a statistically significant increase in the
mean AUC: the improvement was 4% (95% CIs, 0.6%Y6%) with SR
CAD (P = 0.019) and 5% (95% CIs, 0.6%Y10%) with DR FR-CAD
(P = 0.027). No statistically significant differences in AUC were seen
between the SR CAD and DR FR-CAD paradigm (P = 0.330).
Reporting Times
The mean reporting time of the unassisted reading was 318
seconds (95% CI, 264Y371). The SR CAD added a mean of 177
seconds (95% CIs, 137Y217) to the unassisted reading (56% in-
crease). When DR FR-CAD was used, the mean reporting time for
the reader evaluating CAD prompts was 261 seconds (95% CIs,
218Y305); an additional 113 seconds (95% CIs, 97Y135) was re-
quired for the 2-dimensional review (43% increase). The DR FR-
CAD required less reading time than that for SR CAD (378 vs 496;
TABLE 1. Characteristics of the Study Participants and Clinical
Results
Characteristics
No. Patients
(N = 182)
Age at enrollment, y
Median (range) 65 (58Y76)
Sex, n (%)
Female 78 (43)
Male 104 (57)
CAD reading-paradigm order, n (%)
First CTC interpretation* using CAD as second reader 97 (53)
First CTC interpretation* using double reading with
first-reader CAD
85 (47)
Colorectal lesions, n (%)
Negative for cancer or adenoma measuring 6 mm
or larger on CC
89 (49)
No lesions 58 (32)
Advanced adenoma G6 mm 6 (3.3)
Nonadvanced adenoma G6 mm 17 (9.3)
Nonadenomatous polyps† 8 (4.4)
Positive for cancer or adenoma measuring 6 mm or larger
on CC
93 (51)
Advanced adenoma 6Y9 mm 15 (8.2)
Advanced adenoma Q10 mm 48 (26.4)
Nonadvanced adenoma 6Y9 mm 17 (9.3)
Carcinoma‡ 13 (7.1)
*First CTC interpretation: the first CTC evaluation immediately before CC
examination.
†In 8 cases, the index lesion was nonadenomatous: in 3, 3, and 2 cases, this
was a hyperplastic polyp measuring 5 mm or less, a hyperplastic polyps of
6 mm in size, and a normal mucosa 5 mm or less, respectively.
‡ One cancer measured 7 mm on CC.
CAD indicates computer-aided detection; CC, colonoscopy; CTC, com-
puted tomographic colonography.
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$118 seconds; 95% CI, 52Y185; P G 0.001) and was 59 seconds (95%
CI,1Y116) longer than that for the unassisted reading (P = 0.058). The
regression coefficient relating the number of CAD prompts to CAD
reporting time was 13.3 seconds (95% CIs, 5Y22; P = 0.036) for DR
FR-CAD and 8.5 seconds (95% CI, 0.07Y17.3; P = 0.046) for SR
CAD. Difference in regression coefficients was not statistically signif-
icant (P = 0.33). Finally, interpretation of every additional CAD
prompts increased unassisted reporting time by 11.7 seconds (95%CIs,
1.6Y22.3; P = 0.026) with DR FR-CAD and by 6.9 seconds (95% CIs,
j3.5 to 17.1; P = 0.19) with SR CAD.
Per-Polyp Analysis
Colonoscopy identified 163 lesions of 6 mm or larger of any
histological type in 96 patients. Blinded colonoscopy missed 2 polyps:
one 6-mm pedunculated adenoma in the transverse colon and one
6-mm sessile adenoma in the rectum. The distribution, histological
type, and size of the lesions observed at colonoscopy are listed in
Supplemental Digital Content 3 (http://links.lww.com/RLI/A114). There
were one hundred sixty-three 6-mm lesions or larger, regardless of
the histological type, in the 96 patients. Of these, 93 (57%) lesions fell
into the small (6Y9 mm) size category. Within this subgroup of small
polyps, 1 (1%) was a cancer, 30 (32%) were advanced adenomas, 54
(58%) were adenomas, and 8 (9%) were nonadenomatous polyps. Of
the seventy 10-mm lesions or larger, 12 (17%) were cancers and 58
(83%) were advanced adenomas.
Stand-Alone CAD Performance
At a prompts rate of 11.6 (SD, 6.5; range, 1Y40; median, 10)
per series, the CAD sensitivity for lesions of any histology was 85%
(139/163; 95% CI, 79%Y90%) and 91% (64/70; 95% CI, 82%Y97%)
at 6- and 10-mm threshold sizes, respectively. The CAD sensitivity
for cancer was 85% (11/13; 95% CI, 56Y98). Of the 24 lesions
unprompted by CAD, 7 (29%) polyps were invisible on CTC retro-
spective evaluation. As shown in Table 3, CAD sensitivity was higher
for advanced adenomas compared with that of polyps of other his-
tology (ORs, 2.9; 95% CI,1Y8.6; P = 0.030). There was no signifi-
cant correlation between CAD sensitivity and lesion shape (P =
0.700). Similarly, there were no significant differences in sensitivity
for left-sided polyps compared with right-sided polyps (89% vs
83%; P = 0.300).
Per-Polyps Sensitivity of the Readers
Table 3 shows polyp detection of each reading mode according
to various polyp characteristics.
All 13 cancers were correctly diagnosed in the unassisted
reading phase of SR CAD. Two cancers unprompted by CAD were
TABLE 2. Per-Patient Diagnostic Performance of Each Reading Modality Per Lesion Size Category
Unassisted Read SR CAD FR-CAD DR FR-CAD P
Sensitivity, %
Q6 mm 79.6 (74/93)* 86.0 (80/93)* 84.9 (79/93)‡ 89.2 (83/93)*‡ 0.500
(69.9, 87.2) (77.3, 92.3) (76.0, 91.5) (81.1, 94.7)
Q10 mm 93.3 (56/60) 96.7 (58/60) 95.0 (57/60)† 98.3 (59/60)† 1.000
(84.3, 98.1) (84.5, 99.6) (86.1, 99.0) (91.1, 99.9)
Specificity, %
Q6 mm 93.3 (83/89) 89.9 (80/89) 93.3 (83/89) 91.0 (81/89) 1.000
(85.9, 97.5) (81.6, 97.1) (85.9, 97.5) (83.1, 96.0)
Q10 mm 92.6 (113/122) 92.6 (113/122) 93.4 (114/122) 93.4 (114/122) 1.000
(86.5, 96.5) (86.5, 96.6) (87.4, 97.1) (87.4, 97.1)
PPV, %
Q6 mm 92.5 (74/80) 89.9 (80/89) 92.9 (79/85) 91.2 (83/91) 0.884
(84.4, 97.2) (81.6, 95.3) (85.3, 97.4) (83.4, 95.1)
Q10 mm 70.0 (56/80) 65.2 (58/89) 67.1 (57/85) 64.9 (59/91) 0.879
(58.7, 79.7) (54.3, 74.9) (56.0, 76.8) (54.1, 74.6)
NPV, %
Q6 mm 81.4 (83/102) 86.0 (80/93) 87.4 (83/95) 89.0 (81/91) 1.000
(72.4, 88.4) (77.3,92.3) (79.0, 93.3) (80.7, 94.6)
Q10 mm 96.0 (98/102) 97.8 (91/93) 96.9 (94/97) 98.9 (90/91) 0.659
(90.2, 98.9) (92.4, 99.7) (91.2, 99.4) (94.0, 99.9)
Diagnostic performances for adenoma detection are expressed as percentage (number/total number). The 95% confidence intervals are within parentheses.
Positive predictive value indicates the proportion of patients with positive findings at CTC (with a size cutoff of 6 mm) who had lesions on colonoscopy
(of specified size).
Negative predictive value indicates the proportion of patients with negative findings at CTC (with a size cutoff of 6 mm) who had also no lesions colonoscopy
(of specified size).
* At 6-mm threshold, unassisted reading was significantly less sensitive to detect adenomas compared with both CAD reading paradigms (P = 0.020 for SR
CAD and P = 0.039 for DR FR-CAD). Also, sensitivity of FR-CAD was not statistically different than that of the unassisted reading (P = 0.332), SR CAD
(P = 1.000), and DR FR-CAD (P = 0.130).
†At the 10-mm threshold, sensitivity of the unassisted reading was not less than that of SR CAD (P = 0.400) and DR FR-CAD (P = 0.500). Also, differences in
sensitivity between FR-CAD and DR FR-CAD reading were not statistically significant (P = 0.250).
DR FR-CAD indicates double-reading with FR-CAD; FR-CAD, computer-aided detection as a first reader; NPV, negative predictive value; PPV, positive
predictive value; P, comparison between SR CAD versus DR FR-CAD; SR CAD, computer-aided detection as a second reader.
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marked by the radiologists alone during the 2-dimensional review
component of DR FR-CAD. Per-polyp sensitivities of both SR CAD
and DR FR-CAD readings were significantly higher than that of the
unassisted reading. According to the multivariate analysis (Table 4),
the effect of CAD-reading mode on missed detections was not
significant (ORs, 0.9; 95% CIs, 0.5Y1.8; P = 0.868). Of polyps at
least 6 mm in diameter, low-risk adenomas (ORs, 6.7; 95% CIs,
3.6Y12.7; P G 0.001) and polyps unprompted by CAD (ORs, 5.0;
95% CIs, 2.0Y12.0; P = 0.004) had a greater risk to be missed. No
interactions between reading mode and CAD-prompted polyps (P =
0.397) and between reading mode and polyp histology (P = 0.398)
were found. However, there was evidence for a 2-way interaction
between histology and polyp size: for a low-risk adenoma, the risk for
missed detections decreased with increasing polyp size (ORs, 0.37; 95%
CIs, 0.18Y0.78; P = 0.03), whereas, for an advanced adenoma, the
risk did not seem to have any obvious relation with polyp size (ORs, 0.9;
95% CIs, 0.8Y1.03; P = 0.130). Polyps having pedunculated (ORs, 0.14;
95% CIs, 0.03Y0.57; P = 0.006) or sessile (ORs, 0.27; 95% CI,
0.06Y1.04; P = 0.074) shape were less likely to be missed than flat lesions.
An example of a polyp detected using CAD is provided in Figure 2.
Assessment of False-Positive Detections
During the unassisted analysis, there were 19 false-positive de-
tections of 6-mm adenoma or larger in 16 patients (size range, 6Y27 mm,
TABLE 3. The CTC Sensitivity For Lesions Detected at Colonoscopy According to Morphologic and Histologic Features
Category Stand-alone CAD Unassisted Reading SR-CAD FR-CAD DR FR-RAD P*
All polyps
Q6 mm 85 (139/163) 65 (106/163)† 75 (123/163) 67 (110/163 73 (119/163) 0.584
(79 90) (57, 72) (69, 82) (60, 75) (66, 80)
Q10 mm 91 (64/70) 91 (64/70)† 96 (67/70) 86 (60/70) 91 (64/70) 0.449
(83Y97) (83, 97) (89, 99) (75, 93) (82.3, 96.8)
Cancers
Q6 mm 85 (11/13) 100 (13/13) 100 (13/13) 85 (11/13) 100 (13/13) 1.000
(55, 98) (75, 100) (75, 100) (55, 98) (75, 100)
Q10 mm 83 (10/12) 100 (12/12) 100 (12/12) 83 (10/12) 100 (12/12) 1.000
(52, 98) (74, 100) (74, 100) (52, 98) (74, 100)
Advanced adenoma
Q6 mm 91 (80/88) 82 (72/88) 89 (78/88) 83 (73/88) 85 (75/88) 0.579
(83, 96) (72, 89) (80, 94) (73, 90) (76, 92)
Q10 mm 93 (54/58) 90 (52/58) 95 (55/58) 86 (50/58) 90 (52/58) 0.450
(83, 98) (79, 96) (86, 99) (75, 94) (79, 96)
Nonadvanced Adenomas
Q6 mm 78 (42/54) 33 (18/54) 46 (25/54) 43 (23/54) 50 (27/54) 0.610
(64, 88) (21, 47) (34, 62) (29.3, 56.8) (36, 63)
Nonadenomatous polyps
Q6 mm 75 (6/8) 38 (3/8) 88 (7/8) 62.5 (5/8) 50 (4/8) 0.300
(35, 97) (9, 76) (47, 99) (24.5, 91.5) (16, 84)
Sessile 82 (55/67) 48 (32/67) 61 (41/67) 59.0 (39/67) 68 (43/67) 1.000
(71, 90) (35, 60) (49, 74) (46, 71) (55, 79)
Pedunculated 86 (64/74) 77 (57/74) 85 (63/74) 75.7 (56/74) 78 (58/74) 0.3
(77, 93) (66, 86) (75, 92) (64, 85) (67,87)
Flat (a lesion having a
height Gone half the width)
89 (8/9) 44 (4/9) 67 (6/9) 56 (5/9) 56 (5/9) 1.000
(52, 100) (14,79) (30, 93) (21, 86) (21, 86)
Stenosing lesions 88 (6/7) 100 (7/7) 100 (7/7) 100 (7/7) 100 (7/7) 1.000
(42Y100) (59Y100) (59Y100) (59Y100) (59Y100)
Vegetating lesions (endoluminal growing
lesion with a maximum diameter of 93 cm)
100 (7/7) 100 (6/6) 100 (6/6) 100 (6/6) 100 (6/6) 1.000
(54Y100) (54Y100) (54Y100) (54Y100) (54Y100)
Left lesions 83 (85/102) 72 (73/102) 81 (83/102) 72 (73/102) 80 (82/102) 1.000
(75Y90) (62Y80) (72Y88) (62Y80) (71Y87)
Right lesions 88 (54/6) 54 (33/61) 66 (40/61) 56 (34/61) 61 (37/61) 0.645
(78Y95) (41Y67) (52Y77) (42Y69) (47Y73)
Sensitivities for detection of lesions are expressed as percentage (number/total number). The 95% confidence intervals are within parentheses.
*P value for the comparison between SR CAD and DR FR CAD.
†Compared with the unassisted reading, polyp detection significantly increased by using both SR CAD (P G 0.001) and DR FR-CAD (P = 0.040). Differences
in polyp detection were not statistically significant for lesions larger than or equal to 10 mm (P = 0.248 and P = 1.000 for SR CAD and DR FR-CAD, respectively).
CAD indicates computer-aided detection; CTC, computed tomographic colonography; DR FR-CAD, double-reading with FR-CAD; FR-CAD, computer-aided
detection as a first reader; SR CAD, computer-aided detection as a second reader.
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see Supplemental Digital Content 4, http://links.lww.com/RLI/A115).
Application of SR CAD resulted in a total of 8 additional false posi-
tives in 8 patients. With the DR FR-CAD reading, there were 16 false
positives in 12 patients; 2 of these were false positives (13 mm, bulbous
fold; 30 mm, normal anatomy) and were incorrectly reported during the
2-dimensional review component of DR FR-CAD. Of the 14 CAD
detections incorrectly accepted as polyps during the FR-CAD reading,
12 matched false positives of the unassisted reading. Regardless of
paradigm, the most frequent source of false positives was fecal or fluid
residues.
DISCUSSION
According to our prospective study, DR FR-CAD appeared to
be equally effective and more time-efficient in detecting patients with
6-mm or larger adenomas than SR CAD did in a selected setting
represented by the workup of patients with positive FIT results in the
context of a population-based screening program. Of note, we re-
stricted our primary analysis to the detection of neoplastic rather than
morphological equivalents, underlining the clinical importance of our
results. The results of our study are relevant for several reasons.
First, this is the first time that a more automatized human-
CAD integration paradigm has been shown to be equally effective
and more efficient than the conventional second-reader mode. In
other words, the addition of the human component to the first-reader
CAD as a quick correction of eventual electronic (CAD) errors
appeared to be superior in terms of time efficiency to the addition of
an electronic control to a more prolonged unassisted human reading.
Shortening interpretation time (while maintaining an equally high
sensitivity) may be important if a large number of cases must be read
sequentially, which could be the case, in the future, if CTC will be
implemented as a primary screening strategy in low-prevalence
populations. Second, our study has shown that the addition of a
post-CAD human check in the DR FR-CAD scenario allowed the
detection of 2 invasive cancers that would have been missed by the
implausible use of CAD as the only reader in a clinical setting. In-
deed, a simple FR-CAD paradigm without full 2-dimensional review
would have missed 2 cancers. Thus, limiting the human reading to
accept or reject CAD prompts, as previously done in studies on CAD
as first reader,19 would seem at least questionable. Third, our pro-
spective study showed the superiority of CAD-assisted paradigms
to a solely human-unassisted reading, indicating the usefulness of
the implementation of such CAD-assisted paradigms at least in a
screening setting. Of note, this is the first time that DR FR-CAD
appeared to be statistically significantly more accurate than unas-
sisted reading, whereas DR FR-CAD was only shown to be non-
inferior to the unassisted reading in our previous study.24 Moreover,
our study confirmed that the CAD-related increase in sensitivity is
not associated with a relevant reduction in specificity,13,15,38 further
supporting the efficiency and cost-effectiveness of CAD-assisted
paradigms in this setting.
Fourth, our prospective study confirmed the preliminary evi-
dence that the actual CAD contribution to CTC sensitivity is limited
to 6 to 9 mm adenomas,13 the sensitivity for 10-mm lesions or larger
being unaffected by the CAD implementation in our analysis. Even
if the relatively high prevalence of advanced neoplasia within 6 to
9 mm lesions might be related to the selection in our study of par-
ticipants with positive FIT findings, who are probably more likely to
harbor advanced lesions, the increased sensitivity for adenomas of
CAD reading would still be clinically relevant in a screening popu-
lation. Using CTC as a primary screening strategy, the examination
would likely be offered only at long intervals (5Y10 years); therefore,
the issue of missed lesions might be relevant even among people with
a lower prevalence of advanced lesions.
Fifth, our multivariate analysis showed that the CAD-detected
polyps were more likely to be diagnosed, irrespective of the selected
reading paradigm, indicating that CAD features are intrinsic charac-
teristics of CTC-detectable lesions, further validating the addition of
CAD to human reading in CTC setting.39 Indeed, the fact that a small
percentage (G15%) of polyps would be unmarked by CAD does not
seem to influence reader sensitivity with CAD because most of these
would be dismissed anyway at the unassisted reading. Independent
from the reading mode, advanced adenomas had greater chance to be
correctly detected than did low-risk adenomas; however, for the low-
risk adenomas, the chance increased with increasing polyp size.
Validation of a new technology is essential before its imple-
mentation into clinical practice. Thus, we used a rigorous and se-
quential approach to verify the clinical utility of DR FR-CAD that
moved from its initial validation24 to the present clinical verification
by using an independent clinical data set. The 2 studies we performed
are substantially different because of hypotheses, study populations,
readers, comparators, and methods. Our earlier research was a ret-
rospective study, whereas this one was prospective. Data from ret-
rospective studies could not reflect the additional factors that may
influence reader performance when using CAD in a daily clinical
activity. The risk of this effect may have been particularly high with
our earlier study given the small sample size and the artificially
enriched cohort. Also, our early research investigated the diagnostic
performance of DR FR-CAD in comparison with that of the unas-
sisted reading. Thus, there was no evidence of the benefits of this
CAD reading mode in comparison with those of second-reader CAD.
Therefore, a larger study in a specific population that simulated the
real-work practice conditions was necessary to fully evaluate the
clinical potential of DR FR-CAD reading paradigm.
TABLE 4. Results of Multiple Logistic Regression Modeling
Variable Odds Ratio P
Histological type G0.001
Advanced Adenoma (ref ) 1.0
Low-risk adenoma 6.7 (3.6, 12.7)
CAD-reading mode
DR FR-CAD (ref ) 1.0 0.868
SR CAD 0.9 (0.5, 1.8)
CAD detections
Prompted polyps (ref ) 1.0 0.004
Unprompted polyps 5.0 (2.0, 12.0)
Morphology
Flat polyp (ref ) 1.0
Pedunculated polyp 0.14 (0.05, 0.5) 0.006
Sessile polyp 0.27 (0.06, 0.9) 0.073
Polyp diameter  histology
Polyp diameter  advanced adenoma 0.9 (0.8, 1.03) 0.130
Polyp diameter  low-risk adenoma 0.37 (0.18, 0.77) 0.003
Data are the odds of a polyp being incorrectly missed with CAD either for
the 1-unit increase in the explanatory variable (for variables on a continuous
scale) or for each category relative to the odds of baseline category (for cate-
gorical explanatory variables). Data in parentheses are 95% confidence intervals.
Last row highlights the interaction between polyp size and histology.
In the model polyp, diameter is entered as a continuous determinant, being fit
using 2 different indicator variables to advanced adenoma and low-risk adenoma.
Table reports the estimated effect of polyp diameter on the odds of false
negatives in each histological group.
CAD indicates computer-aided detection; DR FR-CAD, double-reading
with FR-CAD; SR CAD, computer-aided detection as a second reader; refer-
ence category.
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The strength of this study is that it has a prospective design;
thus, this is the first time that different CAD readings strategies were
compared in a clinical environment and not, as previous studies, in
a laboratory setting.40 Also, different from our previous study,24 no
artificial selection of patients was performed. The study population
was homogeneous, and patients with positive FIT findings from
a population-based screening were consecutive and prospectively
enrolled. Therefore, the observed prevalence of diseases ensures
that the findings reported here can be generalized to the study
sample to the entire population. Of note, the patients with positive
FIT findings in previous CAD studies were not recruited from a
screening population.13 Such population represents an ideal setting
to assess test accuracy among asymptomatic patients, as already
reported.8 The use of unblinding colonoscopy had a positive effect
on the performance characteristics found in our study. However,
there were limitations. Colonoscopy was performed immediately
after the first CTC interpretation and random allocation of the cases
to either SR CAD or DR FR-CAD was used to reduce potential
biases in the comparison of the 2 CAD readings. In our study, the
readers’ performance immediately before activating SR CAD served
as the unassisted performance accuracy. This sequential design is less
time-consuming and much less expensive to complete with respect to
a full crossover study where all images were separately read without
and with CAD. Sequential design may bias reader performance be-
cause observers may perform differently when they know they will
soon be shown the CAD marks. However, in our study, adenoma
detection of the unassisted reading for adenoma detection was 80%,
which is well within the range of data in many prior CTC studies.7
Thus, this may be indirect evidence that the readers were vigilant
during the unassisted interpretation and that they did not activate CAD
prematurely. The study readers had considerable experience in CTC;
thus, our results may not be able to be generalized to less-experienced
radiologists. Such a study design prevented us from performing a
statistical analysis of interreader variability in the impact of CAD
among the different readers because a much larger sample size would
have been needed. Similar to other studies,7 we deliberately powered
the study only with 6-mm adenomas or larger, which the radiology
community has considered clinically important.41 Although hyper-
plastic polyps may seem indistinguishable from adenomas on CTC
images, they have no malignant potential and consequently, it is less
important to detect them. However, we also performed a per-polyp
analysis for detection of all lesions, without histological restriction.
Finally, our results reflect one particular CAD system; therefore, they
may not be generalized to other systems. Further studies on larger
populations, using different CAD schemes, will be needed to under-
stand how system design and performance may affect results.
In conclusion, when compared with unassisted reading, a
double-reading paradigm in which first-reader CAD is followed by a
fast 2-dimensional review improves the adenoma detection rate to
the same level achieved by a second-reader CAD while decreasing
reporting times. Therefore, it may be an attractive reading in a
screening setting, where cost-effectiveness is an issue.
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